CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-07 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +5,799 | 5,799 | ||
| 2024-05-29 | Jacobson Mark L. Chief Operating Officer | Option exercise | +13,693 | $1.30 | $18K | 13,693 |
| 2024-05-29 | Jacobson Mark L. Chief Operating Officer | Sale | −7,910 | $74.31 | $588K | 5,783 |
| 2024-05-29 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −13,693 | 0 | ||
| 2024-05-29 | Coleman Mark Director | Sale 10b5-1 | −5,248 | $75.14 | $394K | 14,600 |
| 2024-05-28 | Coleman Mark Director | Sale 10b5-1 | −5,249 | $75.21 | $395K | 19,848 |
| 2024-04-01 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +24,662 | $1.30 | $32K | 24,662 |
| 2024-04-01 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −24,662 | $77.24 | $1.9M | 0 |
| 2024-04-01 | Jacobson Mark L. Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,662 | 0 | ||
| 2024-03-15 | JEFFS ROGER Director | Option exercise 10b5-1 | +2,347 | $29.91 | $70K | 123,103 |
| 2024-03-15 | JEFFS ROGER Director | Sale 10b5-1 | −2,347 | $71.61 | $168K | 120,756 |
| 2024-03-15 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,347 | 0 | ||
| 2024-03-14 | JEFFS ROGER Director | Option exercise 10b5-1 | +13,000 | $22.03 | $286K | 133,756 |
| 2024-03-14 | JEFFS ROGER Director | Sale 10b5-1 | −13,000 | $69.70 | $906K | 120,756 |
| 2024-03-14 | JEFFS ROGER Director | Option exercise 10b5-1 | +16,976 | $25.53 | $433K | 137,732 |
| 2024-03-14 | JEFFS ROGER Director | Sale 10b5-1 | −16,976 | $69.70 | $1.2M | 120,756 |
| 2024-03-14 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,000 | 0 | ||
| 2024-03-14 | JEFFS ROGER Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,976 | 0 | ||
| 2024-02-27 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +1,425 | 1,425 | ||
| 2024-02-27 | Saad Mark E Director | Grant or award · Stock Option (Right to Buy) | +1,519 | 1,519 |
Page 12 of 22 · 422 trades